Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Raised by Vivid Wealth Management LLC

Vivid Wealth Management LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the 1st quarter, Holdings Channel.com reports. The firm owned 4,929 shares of the medical equipment provider’s stock after acquiring an additional 50 shares during the period. Intuitive Surgical makes up 1.2% of Vivid Wealth Management LLC’s holdings, making the stock its 29th biggest holding. Vivid Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,441,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. Union Bancaire Privee UBP SA acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $6,509,000. Bank of Stockton lifted its stake in shares of Intuitive Surgical by 13.5% in the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock worth $606,000 after acquiring an additional 138 shares during the period. Bank Pictet & Cie Europe AG lifted its stake in shares of Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock worth $99,678,000 after acquiring an additional 883 shares during the period. Finally, Nations Financial Group Inc. IA ADV lifted its stake in shares of Intuitive Surgical by 5.5% in the 4th quarter. Nations Financial Group Inc. IA ADV now owns 829 shares of the medical equipment provider’s stock worth $433,000 after acquiring an additional 43 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the business’s stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now directly owns 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 1.3%

Shares of ISRG opened at $519.04 on Tuesday. The business’s 50 day moving average is $527.80 and its 200 day moving average is $538.30. The company has a market capitalization of $186.03 billion, a PE ratio of 80.97, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Piper Sandler cut their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Royal Bank of Canada lowered their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.